Literature DB >> 11853396

Generation of E3-deleted canine adenoviruses expressing canine parvovirus capsid by homologous recombination in bacteria.

Mark D Morrison1, Dorothy Reid, David Onions, Norman Spibey, Lesley Nicolson.   

Abstract

E3-deleted canine adenovirus type 1 (CAV-1) was generated by homologous recombination in bacterial cells, using an antibiotic resistance marker to facilitate the recovery of recombinants. This marker was flanked by unique restriction endonuclease sites, which allowed its subsequent removal and the insertion of cassettes expressing the canine parvovirus capsid at the E3 locus. Infectious virus was recovered following transfection of canine cells and capsid expression was observed by RT-PCR from one of the virus constructs. A second construct, containing a different promoter, showed delayed growth and genome instability which, based on the size difference between these inserts, suggests a maximum packaging size of 106 to 109% wild-type genome size for CAV-1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11853396     DOI: 10.1006/viro.2001.1262

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  5 in total

1.  Development and assessment of human adenovirus type 11 as a gene transfer vector.

Authors:  Daniel Stone; Shaoheng Ni; Zong-Yi Li; Anuj Gaggar; Nelson DiPaolo; Qinghua Feng; Volker Sandig; André Lieber
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

2.  A novel recombinant Peste des petits ruminants-canine adenovirus vaccine elicits long-lasting neutralizing antibody response against PPR in goats.

Authors:  Junling Qin; Hainan Huang; Yang Ruan; Xiaoqiang Hou; Songtao Yang; Chengyu Wang; Geng Huang; Tiecheng Wang; Na Feng; Yuwei Gao; Xianzhu Xia
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

Review 3.  Development of nonhuman adenoviruses as vaccine vectors.

Authors:  Dinesh S Bangari; Suresh K Mittal
Journal:  Vaccine       Date:  2005-09-23       Impact factor: 3.641

4.  Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice.

Authors:  Xiu-Zhen Li; Xiao-Hu Wang; Li-Jun Xia; Ya-Biao Weng; Jorge A Hernandez; Li-Qing Tu; Lu-Tao Li; Shou-Jun Li; Zi-Guo Yuan
Journal:  BMC Infect Dis       Date:  2015-03-04       Impact factor: 3.090

5.  Establishment of a Simple and Efficient Reverse Genetics System for Canine Adenoviruses Using Bacterial Artificial Chromosomes.

Authors:  Hiromichi Matsugo; Tomoya Kobayashi-Kitamura; Haruhiko Kamiki; Hiroho Ishida; Akiko Takenaka-Uema; Shin Murakami; Taisuke Horimoto
Journal:  Viruses       Date:  2020-07-16       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.